First Time Loading...

BioLife Solutions Inc
NASDAQ:BLFS

Watchlist Manager
BioLife Solutions Inc Logo
BioLife Solutions Inc
NASDAQ:BLFS
Watchlist
Price: 18.46 USD 1.99%
Updated: Mar 28, 2024

Intrinsic Value

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. [ Read More ]

The intrinsic value of one BLFS stock under the Base Case scenario is 9.46 USD. Compared to the current market price of 18.46 USD, BioLife Solutions Inc is Overvalued by 49%.

Key Points:
BLFS Intrinsic Value
Base Case
9.46 USD
Overvaluation 49%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
BioLife Solutions Inc

Backtest BLFS Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling BLFS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
BioLife Solutions Inc

Current Assets 120.6m
Cash & Short-Term Investments 35.4m
Receivables 18.7m
Other Current Assets 66.5m
Non-Current Assets 292.1m
Long-Term Investments 5.1m
PP&E 40.3m
Intangibles 245.9m
Other Non-Current Assets 821k
Current Liabilities 42.2m
Accounts Payable 6.9m
Accrued Liabilities 19.5m
Other Current Liabilities 15.7m
Non-Current Liabilities 32.9m
Long-Term Debt 19.5m
Other Non-Current Liabilities 13.4m
Efficiency

Earnings Waterfall
BioLife Solutions Inc

Revenue
143.3m USD
Cost of Revenue
-96.5m USD
Gross Profit
46.8m USD
Operating Expenses
-102.1m USD
Operating Income
-55.3m USD
Other Expenses
-11.1m USD
Net Income
-66.4m USD

Free Cash Flow Analysis
BioLife Solutions Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

BLFS Profitability Score
Profitability Due Diligence

BioLife Solutions Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Revenue Growth Forecast
Negative 1-Year Revenue Growth
27/100
Profitability
Score

BioLife Solutions Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.

BLFS Solvency Score
Solvency Due Diligence

BioLife Solutions Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
67/100
Solvency
Score

BioLife Solutions Inc's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLFS Price Targets Summary
BioLife Solutions Inc

Wall Street analysts forecast BLFS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BLFS is 23.75 USD with a low forecast of 20.2 USD and a high forecast of 31.5 USD.

Lowest
Price Target
20.2 USD
9% Upside
Average
Price Target
23.75 USD
29% Upside
Highest
Price Target
31.5 USD
71% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

BLFS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

BLFS Price
BioLife Solutions Inc

1M 1M
+8%
6M 6M
+31%
1Y 1Y
-10%
3Y 3Y
-48%
5Y 5Y
+3%
10Y 10Y
+398%
Annual Price Range
18.46
52w Low
8.99
52w High
24.34
Price Metrics
Average Annual Return 21.18%
Standard Deviation of Annual Returns 93.08%
Max Drawdown -85%
Shares Statistics
Market Capitalization 833.8m USD
Shares Outstanding 45 300 000
Percentage of Shares Shorted 10.94%

BLFS Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

BioLife Solutions Inc Logo
BioLife Solutions Inc

Country

United States of America

Industry

Health Care

Market Cap

833.8m USD

Dividend Yield

0%

Description

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. The company is headquartered in Bothell, Washington and currently employs 432 full-time employees. Its products are used in basic and applied research and commercial manufacturing of biologic-based therapies. The company has a portfolio of tools and services that focus on biopreservation, cell processing, frozen biologic storage products and services, cold-chain transportation, and thawing of biologic materials. Its tools portfolio includes its CryoStor and HypoThermosol biopreservation media for shipping and storage, the ThawSTAR family of automated, water-free thawing products, evo cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. Customers use its products to maintain the health and function of biologic material during sourcing, manufacturing, storage, and distribution.

Contact

WASHINGTON
Bothell
3303 Monte Villa Pkwy Ste 310
+14254011400.0
https://www.biolifesolutions.com/

IPO

1989-11-22

Employees

432

Officers

CEO & Chairman
Mr. Roderick de Greef
Chief Financial Officer
Mr. Troy Wichterman
Chief Quality & Operations Officer
Ms. Karen Foster
Chairman of Scientific Advisory Board, Executive VP & Chief Scientific Officer
Dr. Aby J. Mathew Ph.D.
Consultant
Mr. Michael P. Rice
Chief Marketing Officer
Mr. Todd Berard
Show More
Chief Human Resources Officer
Ms. Sarah Aebersold J.D.
Senior Vice President of Global Operations
Mr. Geraint Phillips
Chief Revenue Officer
Mr. Garrie Richardson B.Sc., M.B.A.
Show Less

See Also

Discover More
What is the Intrinsic Value of one BLFS stock?

The intrinsic value of one BLFS stock under the Base Case scenario is 9.46 USD.

Is BLFS stock undervalued or overvalued?

Compared to the current market price of 18.46 USD, BioLife Solutions Inc is Overvalued by 49%.